医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Anthelio® Creates ICD-10-CM/PCS Trauma Training Program for Michigan Trauma Coalition®

2013年03月07日 PM10:25
このエントリーをはてなブックマークに追加


 

DALLAS

Anthelio Healthcare Solutions Inc. (Anthelio®) and Michigan Trauma Coalition® (MTC) announced that Anthelio has agreed to create and deliver a customized, trauma specific ICD-10-CM/PCS training program for MTC. Anthelio® is a leading provider of comprehensive information technology (IT) services and business process (BP) solutions for healthcare providers. MTC is a non-profit, membership organization comprised of trauma centers, healthcare professionals and organizations dedicated to reducing traumatic injuries.

Anthelio® will create a customized solution for MTC that will provide training necessary to prepare the MTC members for the ICD-10-CM/PCS go-live date in October 2014. The primary objective of MTC is to provide a cost-efficient, compliance-driven ICD-10-CM/PCS training course that will prepare its members for the increased specificity of the ICD-10-CM/PCS update and the associated complexities.

“We understand the importance of learning about the impending changes with ICD-10-CM/PCS and the associated scope and complexity. However, trauma registrars and staff only code for trauma related injuries, procedures, etc. We were looking for training that was specific to our needs. One of the Anthelio representatives provided a brief overview to our State Trauma Registrar Committee which opened the door to discussions that led to the development of this course,” said Joann Burrington, MTC board member and chair of the MI Trauma Nurses Committee. “By selecting Anthelio to create a customized solution for trauma related ICD-10-CM/PCS training, we can better prepare our members for the challenging complexities associated with the new code structure.”

A relationship between the MTC and Anthelio enables the MTC to harness the capabilities and expertise of Anthelio’s ICD-10-CM/PCS AHIMA approved trainers who each have more than 12 years of experience. The Anthelio ICD-10-CM/PCS trauma training program offers trauma centers a customized solution based upon the code sets applicable to a trauma department.

“As a leader in providing coding, medical record and information technology solutions to the hospitals where MTC members are located, Anthelio has the coding expertise, focus and dedication to meet the MTC’s specific needs,” said Rick Kneipper, Anthelio’s CEO (Interim) and Co-Founder. “Backed by our CDI, ICD-10-CM/PCS readiness programs, Anthelio is positioned and prepared to address these challenges for MTC in the most efficient and cost-effective manner.”

About Anthelio

Anthelio® is the largest independent provider of IT and business process (BP) services to hospitals, physician practice groups and other healthcare providers. By provisioning hospitals with comprehensive, high-quality, flexible and secure IT and BP services, Anthelio improves hospitals’ healthcare services while reducing costs and streamlining processes. It leverages knowledge and expertise built over a decade of operations about clinical and administrative IT processes and best practices to provide improved IT and BP services at lower costs to customers. Anthelio is headquartered in Dallas, Texas. For additional information see www.antheliohealth.com.

About Michigan Trauma Coalition

Formed by concerned health care providers in 1991, the Michigan Trauma Coalition is a non-profit, membership organization comprised of trauma centers, health care professionals, and organizations dedicated to reducing traumatic injuries through education and sharing of best practices across the State of Michigan. The mission of the Michigan Trauma Coalition is to promote the optimal care of the injured patient through collaboration as the State moves to implement a statewide trauma system. More information can be found at http://mitrauma.com/.

CONTACT

Anthelio Healthcare
Suresh Singh, 855-268-4354 Ext.4555
Anthelio.communication@antheliohealth.com
or
Michigan
Trauma Coalition

Joann Burrington, 248-849-2729
Joann.Burrington@stjohn.org

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表